Table 1.

Details of patients with evidence of spermatogenesis

Semen analysis
Patient no.
Diagnosis
Age at SCT, y
Conditioning regimen
Follow-up, y
aGVHD, grade
cGVHD, L or E
FSH, 1-15 U/L*
Free testosterone, 0.3123-1.041 μM*
Concentration, >20 × 106/mL*
% motile, >50%*
% normal morphology, >14%*
1   MDS   29   TBI, Cy, Flu   7.1   0   L   17   0.54826   <1†  76*  <1† 
2   CML   20   TBI, Cy   9.8   0   L   11   0.57949   9.3   48   12  
3   CML   30   TBI, Cy   12.3   0   L   23   0.4164   2.7   85   6.9  
4   CML   39   Cy, Flu   7.8   II   E   4   0.51009   39   69   54  
5
 		 CML
 		 40
 		 Cy, Flu
 		 5.6
 		 II
 		 L
 		 5
 		 0.25331
 		 11
 		 78
 		 21
 
Semen analysis
Patient no.
Diagnosis
Age at SCT, y
Conditioning regimen
Follow-up, y
aGVHD, grade
cGVHD, L or E
FSH, 1-15 U/L*
Free testosterone, 0.3123-1.041 μM*
Concentration, >20 × 106/mL*
% motile, >50%*
% normal morphology, >14%*
1   MDS   29   TBI, Cy, Flu   7.1   0   L   17   0.54826   <1†  76*  <1† 
2   CML   20   TBI, Cy   9.8   0   L   11   0.57949   9.3   48   12  
3   CML   30   TBI, Cy   12.3   0   L   23   0.4164   2.7   85   6.9  
4   CML   39   Cy, Flu   7.8   II   E   4   0.51009   39   69   54  
5
 		 CML
 		 40
 		 Cy, Flu
 		 5.6
 		 II
 		 L
 		 5
 		 0.25331
 		 11
 		 78
 		 21
 

L indicates limited; E, extensive; Cy, cyclophosphamide; and Flu, fludarabine.

*

Normal range.

†

Out of 198 fields read, 17 sperm were seen, of which 13 were motile (76% motility).

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal